Perrigo
PRGO
14.55
+0.55
+3.93%
Perrigo
US · PRGO
#2793 by market cap
Listed 1970
14.55
+0.55
+3.93%
Live - 5344 symbols - heartbeat 547s ago
· 2026-10-08 04:09
Pre-market
14.20
-2.41%
After-hours
14.55
0.00%
- Market cap
- 2.02B
- P/E (TTM)i
- -1.16
- P/Bi
- 0.80
- EPSi
- -10.29
- Div yieldi
- 7.97%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on PRGO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- Total institutional ownership fell 6.3 percentage points.
Institutional ownership
- Held by institutions
- 111.36% -6.29pp
- Institutions
- 387
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund92.30%
Hedge Fund11.35%
Public Company3.27%
Sovereign Wealth Fund1.47%
Private Company1.31%
Government Pension Fund1.02%
Individual/Insider0.47%
VC/PE Fund0.43%
Family Office/Trust0.12%
Top holders as of 2026-06-30
BlackRock
16.36% · 22.70M sh
Neuberger Berman Investment Advisers LLC
7.70% · 10.68M sh
Vanguard Portfolio Management, LLC
6.52% · 9.05M sh
State Street Global Advisors
6.15% · 8.53M sh
Fuller & Thaler Asset Management, Inc.
5.40% · 7.50M sh
Vanguard Capital Management, LLC
5.16% · 7.16M sh
Invesco Capital Management LLC
4.12% · 5.72M sh
Dimensional Fund Advisors
3.94% · 5.47M sh
Menora Mivtachim Provident Funds
3.17% · 4.39M sh
Geode Capital Management, LLC
2.61% · 3.62M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Patrick Lockwood-Taylor | Chief Executive Officer | 0.09% |
| Eduardo Bezerra | Chief Financial Officer | 0.06% |
| Geoffrey Parker | Independent Director | 0.06% |
| Robert Willis | Chief Human Resources Officer & Executive VP | 0.04% |
| Bradley Alford | Independent Director | 0.03% |
| Donal O'Connor | Independent Director | 0.03% |
| Ronald Janish | Chief Transformation Officer and Executive VP of Global Operations & Supply Chain | 0.03% |
| Orlando Ashford | Independent Chairperson | 0.02% |
| Adriana Karaboutis | Independent Director | 0.02% |
| Grainne Quinn | Chief Medical Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-10 | Bradley Alford | Independent Director | Derivative Exercise and Sale | -607 | $13.66 |
| 2026-09-10 | Bradley Alford | Independent Director | Other Derivative Acquisition | +2,059 | -- |
| 2026-09-10 | Bradley Alford | Independent Director | Derivative Exercise and Retained | +656 | $13.66 |
| 2026-09-10 | Geoffrey Parker | Independent Director | Derivative Exercise and Sale | -607 | $13.66 |
| 2026-09-10 | Geoffrey Parker | Independent Director | Derivative Exercise and Retained | +656 | $13.66 |
| 2026-09-08 | David Ball | EVP and Chief Brand & Digital Officer | Derivative Exercise and Sale | -2,784 | $14.34 |
| 2026-09-08 | David Ball | EVP and Chief Brand & Digital Officer | Derivative Exercise and Retained | +4,917 | $14.34 |
| 2026-07-07 | Ahmed Amin | Independent Director | Other Derivative Acquisition | +14,964 | -- |
| 2026-07-07 | Albert Manzone | Independent Director | Other Derivative Acquisition | +235,627 | -- |
| 2026-07-07 | Robert Willis | Chief Human Resources Officer & Executive VP | Other Derivative Acquisition | +60,085 | -- |
| 2026-07-07 | Matthew Winterman | Executive Vice President of Product Supply, Operations Strategy & Transformation Officer | Derivative Exercise and Sale | -9,138 | $10.52 |
| 2026-07-07 | Matthew Winterman | Executive Vice President of Product Supply, Operations Strategy & Transformation Officer | Other Derivative Acquisition | +70,688 | -- |
| 2026-07-07 | Matthew Winterman | Executive Vice President of Product Supply, Operations Strategy & Transformation Officer | Derivative Exercise and Retained | +8,365 | $10.52 |
| 2026-07-07 | Eduardo Bezerra | Chief Financial Officer | Other Derivative Acquisition | +141,376 | -- |
| 2026-07-07 | Mohammad Gajial | Independent Director | Other Derivative Acquisition | +14,964 | -- |
| 2026-07-07 | Roberto Khoury | Executive VP & President of Consumer Self-Care International | Derivative Exercise and Sale | -385 | $10.52 |
| 2026-07-07 | Roberto Khoury | Executive VP & President of Consumer Self-Care International | Other Derivative Acquisition | +113,101 | -- |
| 2026-07-07 | Roberto Khoury | Executive VP & President of Consumer Self-Care International | Derivative Exercise and Retained | +352 | $10.52 |
| 2026-07-07 | David Ball | EVP and Chief Brand & Digital Officer | Other Derivative Acquisition | +70,688 | -- |
| 2026-07-07 | Charles Atkinson | General Counsel | Other Derivative Acquisition | +123,704 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:09:47 · For reference only, not investment advice and not tailored to your situation.